Between Folk Medicine and Pharmacological Risk: Non-Conventional Food Plants in Cancer-Associated Thrombosis

Cancer-associated thrombosis (CAT) is the second leading cause of mortality in patients with active malignancy, driven by tumor-induced hypercoagulability and amplified by tyrosine kinase inhibitors (TKIs). Many oncology patients self-medicate with Non-Conventional Food Plants (NCFP) attributed with anticancer properties in Latin American popular medicine, an unstudied issue in anticoagulated oncology patients. Using Petiveria alliacea L. as a case study, this critical review evaluates herb-drug interaction evidence for NCFP bioactives against anticoagulants and anticancer therapies, with attention to INFOGEST 2.0 bioaccessibility. Evidence is classified into clinical, preclinical, and hypothesis tiers, which are often conflated. Clinically, isoquercetin reduced CAT biomarkers in a phase II trial, the only direct human evidence for antithrombotic activity of a quercetin-class compound in cancer patients. Preclinically, quercetin-rich NCFP species show antiplatelet mechanisms in vitro and in animal models, mechanistically consistent with that clinical result. P. alliacea shows an asymmetric profile: in vitro cytotoxicity and a recruiting phase Ib/II trial, against mutagenicity, genotoxicity, and no safety data, with safety prioritized. At the hypothesis tier, structural homology between P. alliacea dibenzyl trisulfide (DTS) and antiplatelet garlic organosulfurs suggests an untested hemostatic mechanism, and quercetin- and DTS-mediated inhibition of cytochrome P450 (CYP) and P-glycoprotein could alter TKI and anticoagulant exposure. Near-total absence of bioaccessibility data for NCFP infusions or decoctions remains the barrier to real-world exposure estimates. NCFP use during anticoagulation for CAT is a plausible but undocumented safety question rather than a demonstrated risk; priorities include bioaccessibility studies, standardized P. alliacea characterization, and culturally competent screening tools.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11535337/v1
Primary Topic
Complementary and Alternative Medicine Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Between Folk Medicine and Pharmacological Risk: Non-Conventional Food Plants in Cancer-Associated Thrombosis

Despoina Pantazi, Renata Adriana Labanca, Silvia Bittner Fialová
Research Square
Complementary and Alternative Medicine Studies
preprint

Between Folk Medicine and Pharmacological Risk: Non-Conventional Food Plants in Cancer-Associated Thrombosis

Despoina Pantazi, Renata Adriana Labanca, Silvia Bittner Fialová
preprint en

Abstract

Cancer-associated thrombosis (CAT) is the second leading cause of mortality in patients with active malignancy, driven by tumor-induced hypercoagulability and amplified by tyrosine kinase inhibitors (TKIs). Many oncology patients self-medicate with Non-Conventional Food Plants (NCFP) attributed with anticancer properties in Latin American popular medicine, an unstudied issue in anticoagulated oncology patients. Using Petiveria alliacea L. as a case study, this critical review evaluates herb-drug interaction evidence for NCFP bioactives against anticoagulants and anticancer therapies, with attention to INFOGEST 2.0 bioaccessibility. Evidence is classified into clinical, preclinical, and hypothesis tiers, which are often conflated. Clinically, isoquercetin reduced CAT biomarkers in a phase II trial, the only direct human evidence for antithrombotic activity of a quercetin-class compound in cancer patients. Preclinically, quercetin-rich NCFP species show antiplatelet mechanisms in vitro and in animal models, mechanistically consistent with that clinical result. P. alliacea shows an asymmetric profile: in vitro cytotoxicity and a recruiting phase Ib/II trial, against mutagenicity, genotoxicity, and no safety data, with safety prioritized. At the hypothesis tier, structural homology between P. alliacea dibenzyl trisulfide (DTS) and antiplatelet garlic organosulfurs suggests an untested hemostatic mechanism, and quercetin- and DTS-mediated inhibition of cytochrome P450 (CYP) and P-glycoprotein could alter TKI and anticoagulant exposure. Near-total absence of bioaccessibility data for NCFP infusions or decoctions remains the barrier to real-world exposure estimates. NCFP use during anticoagulation for CAT is a plausible but undocumented safety question rather than a demonstrated risk; priorities include bioaccessibility studies, standardized P. alliacea characterization, and culturally competent screening tools.

Research Square
Universidade Federal de Minas Gerais (BR), University of Ioannina (GR), Comenius University Bratislava (SK)
Complementary and Alternative Medicine Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon